MedicarePartD.guide

A non-government resource built from CMS public data

Overactive bladder drugs on every 2026 Maine Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 9 stand-alone Part D plans in Maine cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Overactive bladder drugs by 2026 Maine Part D plan
DrugWellcare Classic$0.00/moS4802-075Wellcare Value Script$0.00/moS4802-136HealthSpring Assurance Rx$0.00/moS5617-003Humana Basic Rx Plan$0.00/moS5884-101Humana Value Rx Plan$54.40/moS5884-181AARP Medicare Rx Saver from UHC$82.40/moS5921-378SilverScript Choice$94.90/moS5601-002AARP Medicare Rx Preferred from UHC$104.30/moS5921-384Humana Premier Rx Plan$150.20/moS5884-148
oxybutyningeneric DitropanTier 325%QL 60/30dTier 440%QL 60/30dTier 210%Tier 2$1.00Tier 2$0.00Tier 3PA17%Tier 2$7.00QL 120/30dTier 2PA$10.00Tier 2$4.00
solifenacingeneric VesicareTier 427%QL 30/30dTier 440%QL 30/30dTier 430%Tier 433%QL 30/30dTier 2$0.00QL 30/30dTier 4PA36%QL 30/30dTier 2$7.00QL 30/30dTier 3PA15%QL 30/30dTier 2$4.00QL 30/30d
MyrbetriqmirabegronNot coveredNot coveredTier 325%Tier 325%QL 30/30dTier 320%QL 30/30dNot coveredTier 318%QL 30/30dTier 315%Tier 3$45.00QL 30/30d
mirabegrongeneric MyrbetriqTier 325%QL 30/30dTier 325%QL 30/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
GemtesavibegronNot coveredTier 440%QL 30/30dNot coveredNot coveredNot coveredTier 317%Tier 318%QL 30/30dTier 430%Not covered
tolterodinegeneric DetrolTier 427%QL 60/30dTier 440%QL 60/30dTier 430%Tier 433%QL 60/30dTier 431%QL 60/30dNot coveredTier 433%QL 60/30dTier 430%Tier 450%QL 60/30d
trospiumgeneric SancturaTier 325%QL 60/30dTier 325%QL 60/30dNot coveredTier 433%Tier 431%Not coveredTier 2$7.00QL 60/30dTier 315%Tier 450%

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.